| Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐or very high‐risk myelodysplastic … AM Brunner, J Esteve, K Porkka, S Knapper, E Traer, S Scholl, ... American journal of hematology 99 (2), E32-E36, 2024 | 15 | 2024 |
| Decision-making in uncertain contexts: The role of autonomic markers in resolving indecision T Lees, R White, X Zhang, N Ram, LM Gatzke-Kopp International journal of psychophysiology 177, 220-229, 2022 | 7 | 2022 |
| Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial X Baraliakos, E Pournara, L Gossec, PJ Mease, R White, E O’Brien, ... RMD open 8 (2), e002303, 2022 | 4 | 2022 |
| Testing the efficacy of real-time fMRI neurofeedback for training people who smoke daily to upregulate neural responses to nondrug rewards YI Chung, R White, CF Geier, SJ Johnston, JM Smyth, MR Delgado, ... Cognitive, Affective, & Behavioral Neuroscience 23 (2), 440-456, 2023 | 3 | 2023 |
| POS0930 SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS: PREDICTORS OF RESPONSE FROM THE DOUBLE-BLIND, RANDOMISED, PHASE 3B MAXIMISE TRIAL X Baraliakos, E Pournara, L Gossec, H Marzo-Ortega, PJ Mease, R White, ... Annals of the Rheumatic Diseases 80 (Suppl 1), 728-728, 2021 | 2 | 2021 |
| The association between perinatal hypoxia exposure and externalizing symptoms and children’s decision making in conditions of uncertainty is moderated by DRD2 genotype R White, LM Gatzke-Kopp, PJ Ryan, DM Lydon-Staley Developmental Psychobiology, 2018 | 1 | 2018 |
| SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS: PREDICTORS OF RESPONSE FROM THE DOUBLE-BLIND, RANDOMISED, PHASE 3B MAXIMISE TRIAL LC Coates, X Baraliakos, E Pournara, L Gossec, H Marzo-Ortega, ... RHEUMATOLOGY 61, I143-I143, 2022 | | 2022 |
| P260 Secukinumab in Patients With Psoriatic Arthritis and Axial Manifestations: Predictors of Response From the Double-blind, Randomised, Phase 3b MAXIMISE Trial LC Coates, X Baraliakos, E Pournara, L Gossec, H Marzo-Ortega, ... Rheumatology 61 (Supplement_1), keac133. 259, 2022 | | 2022 |
| Facteurs prédictifs de réponse au sécukinumab chez les patients atteints de rhumatisme psoriasique avec manifestation axiale: analyse post-hoc de l’essai randomisé contrôlé … L Gossec, X Baraliakos, E Pournara, H Marzo-Ortega, PJ Mease, R White, ... Revue du Rhumatisme 88, A225, 2021 | | 2021 |
| Post-inflammatory and Degenerative Changes in Patients with Psoriatic Arthritis and Axial Manifestations: Post-hoc Analysis from a Double-blind, Randomized, Phase 3b Trial X Baraliakos, E Pournara, L Coates, V Navarro-Compan, R White, ... ARTHRITIS & RHEUMATOLOGY 73, 4071-4073, 2021 | | 2021 |
| Electrophysiological Indices of Performance Monitoring in Children R White The Pennsylvania State University, 2019 | | 2019 |
| MIND AND BODY: INVESTIGATING CENTRAL AND AUTONOMIC NERVOUS SYSTEM COUPLING IN THE CONTEXT OF AFFECTIVE MANIPULATION R White, N Ram, L Gatzke-Kopp PSYCHOPHYSIOLOGY 55, S46-S46, 2018 | | 2018 |
| SKIN CONDUCTANCE REACTIVITY MODERATES THE ASSOCIATION BETWEEN DELIBERATION TIME AND WILLINGNESS TO TAKE RISK IN A PROBABILISTIC DECISION-MAKING TASK R White, X Yang, N Ram, L Gatzke-Kopp PSYCHOPHYSIOLOGY 54, S77-S77, 2017 | | 2017 |
Nilam RamStanford UniversityVerified email at stanford.edu
